Neoplasia

Article	Citations
Filamin a binds deleted in liver cancer 1 (DLC1) to promote its tumor suppressor activity and inhibit the SRF coactivator MRTF-A	84
Visualizing mast cell migration to tumor sites using sodium iodide symporter of nuclear medicine reporter gene	82
Corrigendum to “Structure-function studies of the bHLH phosphorylation domain of TWIST1 in prostate cancer cells” [Neoplasia 17 (2014) 85]	80
Corrigendum to “Tumorigenicity of IL-1α- and IL-1β-Deficient Fibrosarcoma Cells” [Neoplasia, Volume 10, Issue 6, June 2008, Pages 549–562]	75
Single cell analysis unveils the commonality and heterogeneity between nasopharyngeal and oropharyngeal carcinoma	70
5-Aza-2′-deoxycytidin (Decitabine) increases cancer-testis antigen expression in head and neck squamous cell carcinoma and modifies immune checkpoint expression, especially in CD39-positive CD8 and CD	60
DHX34 deficiency triggers tumor-intrinsic immunity via a dsRNA-mediated type I interferon pathway activation in HCC	56
Sialylated IgG-activated integrin β4-Src-Erk axis stabilizes c-Myc in a p300 lysine acetyltransferase-dependent manner to promote colorectal cancer liver metastasis	55
ARID1A loss sensitizes colorectal cancer cells to floxuridine	51
Epitranscriptomic mechanisms of androgen signalling and prostate cancer	49
Identification of molecularly targeted therapy-induced immunopeptidome in diffuse midline glioma (DMG)	49
L-methionine promotes CD8+ T cells killing hepatocellular carcinoma by inhibiting NR1I2/PCSK9 signaling	46
High metastatic tumor-derived CXCL16 mediates liver colonization metastasis by inducing Kupffer cell polarization via the PI3K/AKT/FOXO3a pathway	45
Myxoid glioneuronal tumor: Histopathologic, neuroradiologic, and molecular features in a single center series	43
Therapeutic benefit of the dual ALK/FAK inhibitor ESK440 in ALK-driven neuroblastoma	43
Combination of sunitinib and 177Lu-labeled antibody cG250 targeted radioimmunotherapy: A promising new therapeutic strategy for patients with advanced renal cell cancer	41
CCAAT‐enhancer binding protein delta functions as a tumor suppressor gene in acute myeloid leukemia	40
Time-restricted feeding affects the fecal microbiome metabolome and its diurnal oscillations in lung cancer mice	37
Retraction notice to “Role of Autophagy as a Survival Mechanism for Hypoxic Cells in Tumors” [Neoplasia 18 (2016) 347- 355/201]	37
RUNX2 enhances bladder cancer progression by promoting glutamine metabolism	36
From adenoma to CRC stages: the oral-gut microbiome axis as a source of potential microbial and metabolic biomarkers of malignancy	36
Mutational signatures and their association with survival and gene expression in urological carcinomas	36
Tumor-Infiltrating Immune Cells in Colorectal Cancer	36
New horizons in B-cell lymphoma immunotherapy: From immune checkpoints to precision medicine	35
BPGM as an intrinsic brake to constrain metastasis through phospho-epigenetic-mediated carnitine biosynthesis suppression	34

Metabolic and imaging phenotypes associated with RB1 and TP53 loss in prostate cancer	34
Rezatapopt: A promising small-molecule “refolder” specific for TP53Y220C mutant tumors	34
The role of glycolysis in tumorigenesis: From biological aspects to therapeutic opportunities	32
Identification of recurrent BRAF non-V600 mutations in intraductal carcinoma of the prostate in Chinese populations	32
A spatiotemporal atlas of orchiectomy-induced androgen deprivation-mediated modulation of cellular composition and gene expression in the mouse prostate	31
Advanced progress of spatial metabolomics in head and neck cancer research	30
PDGFRα governs multiple cellular signals and plays a protective role in tumor progression	29
Regulatory mechanisms of the Hippo/YAP axis by G-protein coupled estrogen receptor in gastric signet-ring cell carcinoma	28
Colorectal cancer, Vitamin D and microbiota: A double-blind Phase II randomized trial (ColoViD) in colorectal cancer patients	28
Epigenetic DNA modifications and vitamin C in prostate cancer and benign prostatic hyperplasia: Exploring similarities, disparities, and pathogenic implications	28
Lactate promoted cisplatin resistance in NSCLC by modulating the m6A modification-mediated FOXO3/MAGI1-IT1/miR-664b-3p/IL-6R axis	28
Innate immunity: Looking beyond T-cells in radiation and immunotherapy combinations	27
Leptomeningeal dissemination in pediatric brain tumors	27
An open-label study to determine the maximum tolerated dose of oral ESK-440 administered as a single agent in patients with advanced or metastatic solid tumors	26
Corrigendum to: The SRSF3-MBNL1-Acin1 circuit constitutes an emerging axis to lessen DNA fragmentation in colorectal cancer via an alternative splicing mechanism	26
Evidence based on Mendelian randomization: Causal relationship between mitochondrial biological function and lung cancer and its subtypes	26
PRAS40 activates the IRE1α-XBP-1-mediated unfolded protein response to exacerbate colorectal cancer by enhancing ST6Gal1-dependent α-2, 6 sialylation of GRP78	25
A novel regimen for pancreatic ductal adenocarcinoma targeting MEK, BCL-xL, and EGFR	25
Aurkin-A, a TPX2-Aurora A small molecule inhibitor disrupts Alisertib-induced polyploidy in aggressive diffuse large B cell lymphoma	25
Single-cell proteomic analysis reveals Multiple Myeloma heterogeneity and the dynamics of the tumor immune microenvironment in precursor and advanced states	24
Reciprocal regulation of lncRNA MEF and c-Myc drives colorectal cancer tumorigenesis	24
PDGF-BB overexpression in p53 null oligodendrocyte progenitors increases H3K27me3 and induces transcriptional changes which favor proliferation	24
Tumor-associated macrophages promote bladder cancer metastasis through the CCL20-CCR6 axis	24
Longitudinal genomic alternations and clonal dynamics analysis of primary malignant melanoma of the esophagus	23
Aurora kinase B is required for growth and expansion of medulloblastoma cells in the tissue context	23
β-Catenin mediated TAM phenotype promotes pancreatic cancer metastasis via the OSM/STAT3/LOXL2 axis	23
A systematic review of microbiome-derived biomarkers for early colorectal cancer detection	23
Incidence, mortality, and global burden of retinoblastoma in 204 countries worldwide from 1990 to 2021: Data and systematic analysis from the Global Burden of Disease Study 2021	23
Indigenous peoples and inclusion in clinical and genomic research: Understanding the history and navigating contemporary engagement	22
Overexpression of the miR-17-92 cluster in colorectal adenoma organoids causes a carcinoma-like gene expression signature	22
Corrigendum to “SPOP promotes CDCA5 degradation to regulate prostate cancer progression via the AKT Pathway” [Neoplasia (2021) 23, 1037–1047]	22
Medication adjustment of afatinib and combination therapy with sitagliptin for alleviating afatinib-induced diarrhea in rats	22
Fusobacterium is enriched in oral cancer and promotes induction of programmed death-ligand 1 (PD-L1)	21
HSP90 C-terminal domain inhibition promotes VDAC1 oligomerization via decreasing K274 mono-ubiquitination in Hepatocellular Carcinoma	21
Enhancing the antitumor efficacy using a combination of FGFR4 Inhibitor (H3B-6527) and oxaliplatin in gastric cancer	21
Acral melanoma: new insights into the immune and genomic landscape	21
Composition of gastrointestinal microbiota in association with treatment response in individuals with metastatic castrate resistant prostate cancer progressing on enzalutamide and initiating treatment	20
The DNA mismatch repair protein, MSH6 is a novel regulator of PD-L1 expression	20
Inhibiting HnRNP L-mediated alternative splicing of EIF4G1 counteracts immune checkpoint blockade resistance in Castration-resistant prostate Cancer	20
SLC31A1 promotes chemoresistance through inducing CPT1A-mediated fatty acid oxidation in ER-positive breast cancer	20
PBI-05204, a supercritical CO2 extract of Nerium oleander, suppresses glioblastoma stem cells by inhibiting GRP78 and inducing programmed necroptotic cell death	19
High dose acetaminophen re-polarizes CD11b+ cells in the tumor microenvironment towards an activated macrophage phenotype	19
Characterizing the impact of MLL fusion variants and fusion partners on leukemia plasticity using a human CRISPR-engineered MLL-rearranged leukemia model	19
IGDQ motogenic peptide gradient induces directional cell migration through integrin (αv)β3 activation in MDA-MB-231 metastatic breast cancer cells	19
Pediatric neuro-oncology: Highlights of the last quarter-century	19
Spatial profiling of METex14-altered NSCLC under tepotinib treatment: Shifting the immunosuppressive landscape	18
Experimental study of tumor-associated macrophage-derived SPP1 inhibit CD8+ T cells to promote Colorectal cancer progression	18
BRAF p.V600E mutation as a molecular boundary between genuine oligo-repeated and poly-metastatic disease in colorectal cancer	18
MYH knockdown in pancreatic cancer cells creates an exploitable DNA repair vulnerability	17
High-throughput sequencing and in-silico analysis confirm pathogenicity of novel MSH3 variants in African American colorectal cancer	17

Comparative effects of combustible cigarette versus electronic cigarette exposures on KRAS mutant lung cancer promotion	17
Identification of TUBB3 as an immunotherapy target in lung cancer by genome wide in vivo CRISPR screening	17
Dopamine receptor D2 regulates glioblastoma survival and death through MET and death receptor 4/5	17
Therapeutic HDAC inhibition in hypermutant diffuse intrinsic pontine glioma	16
PAX8 modulates the tumor microenvironment of high grade serous ovarian cancer through changes in the secretome	16
Early separation and parallel clonal selection of dedifferentiated and well-differentiated components in dedifferentiated liposarcoma	16
Structure and function of the lysine methyltransferase SETD2 in cancer: From histones to cytoskeleton	16
Recent progress and novel approaches to treating atypical teratoid rhabdoid tumor	16
Microbial crosstalk along the oral–gut axis: organ-specific oncogenic adaptations of Porphyromonas gingivalis and Fusobacterium nucleatum	16
Carcinogenesis induced by space radiation: A systematic review	16
Clonal architecture of FLT3-ITD and acquired 13q uniparental disomy define prognostic heterogeneity and therapeutic vulnerabilities in acute myeloid leukemia	15
Corrigendum to “Characterizing the Therapeutic Potential of a Potent BET Degrader in Merkel Cell Carcinoma” [Neoplasia, Volume 21, Issue 3 (2019) 322–330]	15
Current state of pediatric neuro-oncology imaging, challenges and future directions	15
Dynasore as a dual modulator of lipid rafts and cell death in pancreatic cancer	15
Genomics driven precision oncology in advanced biliary tract cancer improves survival	14
Why haven't we solved intracranial pediatric ependymoma? Current questions and barriers to treatment advances.	14
Targeting myeloma metabolism: How abnormal metabolism contributes to multiple myeloma progression and resistance to proteasome inhibitors	14
Dual CDK4/6–PI3K/mTOR inhibition reinforces cytostatic programs and tumor control in preclinical models of primary and metastatic osteosarcoma	14
Unveiling the impact of SUMOylation at K298 site of heat shock factor 1 on glioblastoma malignant progression	14
Metformin use and survival in people with ovarian cancer: A population-based cohort study from British Columbia, Canada	14
Systemic inflammation in response to radiation drives the genesis of an immunosuppressed tumor microenvironment	14
PIK3CA mutant cervical cancer is selectively suppressed by PI3Kα inhibition (Alpelisib/BYL-719 and Inavolisib/GDC-0077) and cooperates with HPV directed T cell therapy	14
Bacterial translocation and barrier dysfunction enhance colonic tumorigenesis	14
Impact of tissue penetration and albumin binding on design of T cell targeted bispecific agents	13
FAPα and αSMA mark different subsets of fibroblasts in normal kidney and conventional renal cell carcinoma	13
Proteomic profiling of canine fibrosarcoma and adjacent peritumoral tissue	13
Oral bioavailable ITRI-148 degrades androgen receptor variants and overcomes antiandrogen resistance in advanced prostate cancer	13
From inflammation to malignancy: the dynamic evolution of cancer-associated fibroblasts in IBD-CRC	13
Genetic loss of CHD1 regulates distinct histone post-translational modifications in the development of castration-resistant prostate cancer	13
Tamoxifen promotes metastasis of breast cancer via reshaping lipid-driven fibrotic microenvironments in the lung	13
LncRNA HOTAIRM1 promotes radioresistance in nasopharyngeal carcinoma by modulating FTO acetylation-dependent alternative splicing of CD44	13
Motion based ex vivo (MOTEX) culture of breast tumor slices sustains microenvironment composition	13
Corrigendum to “Tumor Therapy Mediated by Lentiviral Expression of shBcl-2 and S-TRAIL” [Neoplasia. Vol. 9, No. 5, May 2007, pp. 435–442]	13
Spatial organization of heterogeneous immunotherapy target antigen expression in high-grade glioma	13
CYP1B1 promotes angiogenesis and sunitinib resistance in clear cell renal cell carcinoma via USP5-mediated HIF2α deubiquitination	13
Steatohepatitis alters lymphocytes cytotoxicity and localization, accelerating colorectal liver metastases	13
DARPP-32 and t-DARPP in the development of resistance to anti-HER2 agents. Pre-clinical evidence from the STEP study	13
Phase I clinical trial of a novel procaspase-3 activator SM-1 with temozolomide in recurrent high-grade gliomas	12
Regulation of prostate-specific membrane antigen (PSMA) expression in prostate cancer cells after treatment with dutasteride and lovastatin	12
Synergizing radiotherapy and immunotherapy: Current challenges and strategies for optimization	12
A novel microprotein MUCP1 promotes colorectal cancer metabolic reprogramming by regulating mitochondrial succinate transport	12
Corrigendum to “DNA-methylation eraser TET2 activates WTIP expression to suppress an AKT-dependent chemoresistance of gastric cancer” [Neoplasia volume 2025 Apr 24:65:101166]	12
Comprehensive profiling of EGFR mutation subtypes reveals genomic-clinical associations in non-small-cell lung cancer patients on first-generation EGFR inhibitors	12
Molecular landscape and clinical translation of DNA damage response alterations in solid tumors: A pan-cancer perspective on precision oncology	12
SMARCA4 deficiency in glioblastoma: Mitochondrial transfer from MSCs and the clinical dilemma in targeting the tumor microenvironment	12
Activation of PERK/eIF2α/ATF4 signaling inhibits ERα expression in breast cancer	12
Differential prognostic association of systemic inflammatory biomarkers on survival outcomes in head and neck squamous cell carcinoma patients by human papillomavirus status	12
ΔNp63 silencing, DNA methylation shifts, and epithelial-mesenchymal transition resulted from TAp63 genome editing in squamous cell carcinoma	12
The kinetics of blast clearance are associated with copy number alterations in childhood B-cell acute lymphoblastic leukemia	11
Saturated fat exacerbates mitochondrial dysfunction through remodelling of ATP production and inflammation in Barrett’s oesophagus compared to monounsaturated fat, particularly in contrast to oesophag	11
Systematic analysis of hippo pathway signaling identifies TEAD1 as a transcriptional regulator of neuroendocrine prostate cancer	11
RUNX2 prompts triple negative breast cancer drug resistance through TGF-β pathway regulating breast cancer stem cells	11
Contribution of the immune bone marrow microenvironment to tumor growth and bone deconstruction: implications for improving immunotherapeutic strategies in bone metastasis	11
circUBR5 promotes ribosome biogenesis and induces docetaxel resistance in triple-negative breast cancer cell lines via the miR-340-5p/CMTM6/c-MYC axis	11
Maestros of malignancy: Microbes as the conductors of carcinogenesis	11
Corrigendum to “Single-cell proteomic analysis reveals Multiple Myeloma heterogeneity and the dynamics of the tumor immune microenvironment in precursor and advanced states” [Neoplasia 66 (2025) 11011	11
Metformin combined with cisplatin reduces anticancer activity via ATM/CHK2-dependent upregulation of Rad51 pathway in ovarian cancer	11
Targeting of oncogenic AAA-ATPase TRIP13 reduces progression of pancreatic ductal adenocarcinoma	11
AEBP1 promotes papillary thyroid cancer progression by activating BMP4 signaling	11
Clinical and genetic drivers of oligo-metastatic disease in colon cancer	11
Deletion of the transcription factor ATF4 in a model of clear cell renal cell carcinoma	11
The TRIM22-CDT2 axis is the key mediator of the p53-Rb signals in growth control of HPV-positive cervical carcinoma cells	11
Generation of orthotopic intracranial glioblastoma patient-derived xenograft models: insights into extrachromosomal DNA-driven MYC(N) and PDGFRA oncogene amplification and preliminary therapeutic eval	11
Multimodal profiling of oral squamous cell carcinoma identifies genomic alterations and expression programs associated with betel quid chewing	11
Targeting monopolar spindle kinase I (Mps1 or TTK) induces radiosensitization in syngeneic models of triple negative breast cancer (TNBC) and potentiates type I interferon (T1IFN) signaling	11
Furin, ADAM, and γ-secretase: Core regulatory targets in the Notch pathway and the therapeutic potential for breast cancer	11
RRM2 inhibition alters cell cycle through ATM/Rb/E2F1 pathway in atypical teratoid rhabdoid tumor	11
Common and distinct patterns of acquired uniparental disomy and homozygous deletions between lung squamous cell carcinomas and lung adenocarcinoma	11
ESM1 drives cancer angiogenesis and bevacizumab resistance via trioleate synthesis	10
Histone H3 K27M-mediated regulation of cancer cell stemness and differentiation in diffuse midline glioma	10
Non-melanoma skin cancers: physio-pathology and role of lipid delivery systems in new chemotherapeutic treatments	10
Targeting Wnt/β-catenin signaling enhances the efficacy of anti-CD38 immunotherapy in multiple myeloma	10
SCFβ-TrCP targets Ajuba for degradation in a GSK3β-dependent manner in colorectal cancer	10
Decoding androgen receptor signalling: Genomic vs. non-genomic roles in prostate cancer	10
Immunohistochemical and molecular evolutionary features of jejunoileal adenocarcinoma unveiled through comparative analysis with colorectal adenocarcinoma	10
PRMT1 methylates METTL14 to modulate its oncogenic function	10
Cardiac substructures dosimetric predicts cardiac toxicity and prognosis in esophageal squamous cell cancer treated by radiotherapy	10
Targeting interleukin 4 receptor alpha on tumor-associated macrophages reduces the pro-tumor macrophage phenotype	10
The antitumor activity of osimertinib plus palbociclib in non-small cell lung cancer patient-derived xenograft (PDX)/2D/3D culture models harboring EGFR amplification and CDKN2A/2B homozygous deletion	10
LGR6-dependent conditional inactivation of E-cadherin and p53 leads to invasive skin and mammary carcinomas in mice	9

Non-canonical olfactory pathway activation induces cell fusion of cervical cancer cells	9
Machine Learning-assisted immunophenotyping of peripheral blood identifies innate immune cells as best predictor of response to induction chemo-immunotherapy in head and neck squamous cell carcinoma –	9
Post-irradiation intratumoral heterogeneity modulates response to immune checkpoint inhibition therapy in a murine melanoma model	9
The promise of metabolic imaging in diffuse midline glioma	9
High-dose DFMO alters protein translation in neuroblastoma	9
Tackling ALT-positive neuroblastoma: is it time to redefine risk classification systems? A systematic review with IPD meta-analysis	9
Corrigendum to “P53-independent partial restoration of the p53 pathway in tumors with mutated p53 through ATF4 transcriptional modulation by ERK1/2 and CDK9” [Neoplasia, volume 23 (2021) 304325]	9
Modulation of mitochondrial function by extracellular acidosis in tumor cells and normal fibroblasts: Role of signaling pathways	9
Tumor-associated tissue eosinophilia promotes angiogenesis and metastasis in head and neck squamous cell carcinoma	9
S-adenosylmethionine blocks tumorigenesis and with immune checkpoint inhibitor enhances anti-cancer efficacy against BRAF mutant and wildtype melanomas	8
Past, present and future of Focused Ultrasound as an adjunct or complement to DIPG/DMG therapy: A consensus of the 2021 FUSF DIPG meeting	8
LOXL2⁺ cancer-associated fibroblasts shape WNT signaling to drive chemoresistance and poor outcomes in colorectal cancer: Insights from multi-omics and epidemiological analyses	8
Molecular heterogeneity in histomorphologic subtypes of lung adeno carcinoma represents a challenge for treatment decision	8
An antibody targeting an immune checkpoint molecule BTN2A2 enhances anti-tumor immunity	8
Galectin-3 secreted by triple-negative breast cancer cells regulates T cell function	8
An effective multistage mouse model of esophageal carcinogenesis for preclinical and computational pathology applications	8
Prenatal p25-activated Cdk5 induces pituitary tumorigenesis through MCM2 phosphorylation-mediated cell proliferation	8
Quantitative dissection of radioresistance in cancer cells: Oxygen depletion-induced biological versus chemical mechanisms and baseline mechanisms governed by HIF-1β-NRF2/TXNRD1	8
Therapeutic avenues for targeting treatment challenges of diffuse midline gliomas	8
Microbial molecules, metabolites, and malignancy	8
RANKL and CSF-1 are elevated in periovulatory follicular fluid of BRCA1 mutation carriers and increase proinflammatory signaling in fallopian tube epithelial cells	8
Expression of gemcitabine metabolizing enzymes and stromal components reveal complexities of preclinical pancreatic cancer models for therapeutic testing	8
IL-6 facilitates cross-talk between epithelial cells and tumor- associated macrophages in Helicobacter pylori-linked gastric carcinogenesis	8
The pan-cancer landscape of abnormal DNA methylation and intratumor microorganisms	8
MYC alterations in multiple myeloma: Genetic insights and prognostic impact	8
Proteomic analysis uncovers biological diversity in molecularly defined endometrial carcinomas	8
Integrating single-cell and spatial transcriptomics to dissect mast-cell heterogeneity and arginine-metabolism-associated markers in BRCA	8
Hepatocellular loss of mTOR aggravates tumor burden in nonalcoholic steatohepatitis-related HCC	8
Kv11.1-dependent senescence activates a lethal immune response via tumor necrosis factor alpha	8
Mitochondrial adaptation decreases drug sensitivity of persistent triple negative breast cancer cells surviving combinatory and sequential chemotherapy	8
The chemokine CX3CL1 promotes intraperitoneal tumour growth despite enhanced T-cell recruitment in ovarian cancer	8
White-to-brown adipose switching promotes bladder cancer progression	8
Neuropilin-2 upregulation by stromal TGFβ1 induces lung disseminated tumor cells dormancy escape and promotes metastasis outgrowth	8
Extracellular signals induce dynamic ER remodeling through αTAT1-dependent microtubule acetylation	7
Depletion of β1,6-N-acetylglucosaminyltransferase reduces E-selectin binding capacity and migratory potential of human gastrointestinal adenocarcinoma cells	7
Engineering and characterization of Hu3A4: A novel humanized antibody with potential as a therapeutic agent against myeloid lineage leukemias	7
Comprehensive genomic profiling of Finnish lung adenocarcinoma cohort reveals high clinical actionability and SMARCA4 altered tumors with variable histology and poor prognosis	7
Comparison of adjuvant gemcitabine plus S-1 with S-1 monotherapy for pancreatic ductal adenocarcinoma: Retrospective real-world data	7
Exposure to diesel particulates induces an immunosuppressive microenvironment that promotes the progression of lung cancer	7
Insights into the metastatic bone marrow niche gained from fibronectin and β1 integrin transgenic mice	7
A synergistic approach for modulating the tumor microenvironment to enhance nano-immunotherapy in sarcomas	7
Overcoming ABCB1-mediated multidrug resistance by transcription factor BHLHE40	7
SOMCL-19-133, a novel, selective, and orally available inhibitor of NEDD8-activating enzyme (NAE) for cancer therapy	7
Granulocyte-macrophage colony-stimulating factor for newly diagnosed glioblastoma	7
Cell communication pathway prognostic model identified detrimental neurodevelopmental pathways in neuroblastoma	7
Who benefit from adjuvant chemotherapy in stage I lung adenocarcinoma? A multi-dimensional model for candidate selection	6
Ataxia telangiectasia mutated (ATM) kinase as a predictive biomarker in clinical oncology: implications for a precision treatment approach	6
OTUD4 regulates pancreatic cancer progression via Hippo/YAP axis	6
FER kinase governs invasive growth of head and neck squamous cell carcinoma through dynamic control of growth factor receptor activity	6
Multi-omics profiling reveals microenvironmental remodeling as a key driver of house dust mite-induced lung cancer progression	6
Histone 3 lysine 56 acetylation (H3K56ac) regulates extrachromosomal DNA (ecDNA) hub maintenance	6
PI3K-CCL2-CCR2-MDSCs axis: A potential pathway for tumor Clostridia-promoted CD 8+ T lymphocyte infiltration in bile tract cancers	6
Retraction notice to “Inhibition of HDACs reduces Ewing sarcoma tumor growth through EWS-FLI1 protein destabilization” [Neoplasia 27 (2022) 100784]	6
Targeting the ANXA2-CD63-exosomal PD-L1 axis in hepatocellular carcinoma: A novel mechanism of immune evasion and its implications for precision immunotherapy	6
Sequential treatment of anti-PD-L1 therapy prior to anti-VEGFR2 therapy contributes to more significant clinical benefits in non-small cell lung cancer	6
miRTARGET: An integrated web tool for the identification of microRNA targets with potential therapeutic or prognostic value in cancer	6
Corrigendum to “Protein phosphatase 2A negatively regulates eukaryotic initiation factor 4E phosphorylation and eIF4F assembly through direct dephosphorylation of Mnk and eIF4E” [Neoplasia, volume 12,	6
[18F]-FLT-PET to evaluate how the sequencing of chemotherapies impacts the efficacy of combination treatment in mouse models of triple-negative breast cancer	6
Disruption of redox balance in glutaminolytic triple negative breast cancer by inhibition of glutaminase and glutamate export	6
Corrigendum to Hypoxia induces docetaxel resistance in triple-negative breast cancer via the HIF-1 α/miR-494/Survivin signaling pathway [Volume 32 Number xxx Month 2022 pp. 100821]	6
YPEL2 regulates the efficacy of BRD4-EZH2 dual targeting in EZH2Y641mut germinal center-derived lymphoma	6
Exosomes in review: A new frontier in CAR-T cell therapies	6
Tumor neoantigens as key drivers of significant anti - tumor immunity in triple - negative breast cancer mouse models	6
Adverse prognosis of GM-CSF expression in human cutaneous melanoma	6
Corrigendum to “6-Aminonicotinamide, a G6PD inhibitor, mitigates CAPS1 reduction mediated HCC metastasis via ERK and GSK3β signals” [Neoplasia volume 70 (2025) 101239]	6
Comparison of differences in transcriptional and genetic profiles between intra-central nervous system and extra-central nervous system large B-cell lymphoma	6
Pediatric low-grade glioma: Targeted therapeutics and clinical trials in the molecular era	5
Non-redundant roles of the CCR1 and CCR2 chemokine axes in monocyte recruitment during lung metastasis	5
Disitamab vedotin combined with toripalimab and radiotherapy for multimodal organ-sparing treatment of muscle invasive bladder cancer: a proof-of-concept study	5
PIK3R1 fusion drives chemoresistance in ovarian cancer by activating ERK1/2 and inducing rod and ring-like structures	5
Construction of self-driving anti-αFR CAR-engineered NK cells based on IFN-γ and TNF-α synergistically induced high expression of CXCL10	5
A trio of tumor suppressor miRNA downregulates CREB5 dependent transcription to modulate neoadjuvant hormonal therapy sensitivity	5
Proteomic characterization of the pseudocapsule of clear cell renal cell carcinoma in VHL disease reveals a distinct microenvironment at the tumor boundary zone	5
Retraction notice to Corrigendum to “Inhibition of HDACs reduces Ewing sarcoma tumor growth through EWS-FLI1 protein destabilization” [Neoplasia 31 (2022) 100805]	5
Radiotherapy combined with docetaxel alters the immune phenotype of HNSCC cells and results in increased surface expression of CD137 and release of HMGB1 of specifically HPV-positive tumor cells	5
Emerging role of necroptosis, pyroptosis, and ferroptosis in breast cancer: New dawn for overcoming therapy resistance	5
Dihydroartemisinin, a potential PTGS1 inhibitor, potentiated cisplatin-induced cell death in non-small cell lung cancer through activating ROS-mediated multiple signaling pathways	5
Prognostic role of high MTAP expression is reversed by the ERG status in prostate cancer treated by radical prostatectomy	5
Antibiotic treatment targeting gram negative bacteria prevents neratinib-induced diarrhea in rats	5
Metabolic reprogramming by adenosine antagonism and implications in non-small cell lung cancer therapy	5
Transcriptomic and proteomic profiling identifies feline fibrosarcoma as clinically amenable model for aggressive sarcoma subtypes	5
Cell type composition in bulk prostate cancer tissue is a prognostic biomarker	5
Characterization and integrated analysis of extrachromosomal DNA amplification in hematological malignancies	5
True cancer stem cells exhibit relative degrees of dormancy and genomic stability	5
Establishing a comprehensive panel of patient-derived xenograft models for high-grade endometrial carcinoma: molecular subtypes, genetic alterations, and therapeutic target profiling	5
PD-L1(+) tumor-associated macrophages induce CD8(+) T Cell exhaustion in hepatocellular carcinoma	5
Interdisciplinary care of children with diffuse midline glioma	5
Identification of 68 HLA-A24 and -A2-restricted cytotoxic T lymphocyte-inducing peptides derived from 10 common cancer-specific antigens frequently expressed in various solid cancers	5
Enhanced Apc adenoma formation after epithelial CUL4B deletion by recruitment of myeloid-derived suppressor cells	5
Effect of MisMatch repair deficiency on metastasis occurrence in a syngeneic mouse model	5
Specifying the choice of EGFR-TKI based on brain metastatic status for advanced NSCLC with EGFR p.L861Q mutation	5
GRP78 inhibitor YUM70 upregulates 4E-BP1 and suppresses c-MYC expression and viability of oncogenic c-MYC tumors	5
Corrigendum to “Hedgehog/GLI1 Transcriptionally Regulates FANCD2 in Ovarian Tumor Cells: Its Inhibition Induces HR-Deficiency and Synergistic Lethality with PARP Inhibition.” [Neoplasia Volume 23, Iss	5
A MYC family switch: L-MYC drives and maintains neuroendocrine lineage programs in prostate cancer	5
Effects of PYCR1 on prognosis and immunotherapy plus tyrosine kinase inhibition responsiveness in metastatic renal cell carcinoma patients	5